Quest Diagnostics Incorporated

140.31+2.89+2.10%Vol 923.35K1Y Perf 6.37%
Jun 24th, 2022 16:03 DELAYED
BID137.26 ASK146.50
Open138.60 Previous Close140.31
Pre-Market- After-Market140.31
 - -  - -%
Target Price
149.00 
Analyst Rating
Hold 2.60
Potential %
6.19 
Finscreener Ranking
★★+     46.52
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     52.77
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.75
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★★     44.77
Price Range Ratio 52W %
30.68 
Earnings Rating
Neutral
Market Cap16.47B 
Earnings Date
21st Jul 2022
Alpha-0.00 Standard Deviation0.09
Beta1.06 

Today's Price Range

137.46140.48

52W Range

125.33174.16

5 Year PE Ratio Range

10.8025.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
7.40%
1 Month
-0.51%
3 Months
-2.62%
6 Months
-16.01%
1 Year
6.37%
3 Years
39.06%
5 Years
27.90%
10 Years
164.29%

TickerPriceChg.Chg.%
DGX140.312.89002.10
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.50
0.41
0.73
17.70
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
38.20
24.10
28.00
16.60
18.38
RevenueValueIndustryS&P 500US Markets
10.68B
90.99
12.59
7.43
DividendsValueIndustryS&P 500US Markets
2.02
2.64
5.74
7.48
Payout ratio14.00
Earnings HistoryEstimateReportedSurprise %
Q01 20222.913.2210.65
Q04 20213.353.33-0.60
Q03 20212.963.9633.78
Q02 20212.873.1810.80
Q01 20213.773.76-0.27
Q04 20204.284.484.67
Q03 20203.754.3114.93
Q02 20201.411.420.71
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.150.47Positive
9/2022 QR1.96-2.00Negative
12/2022 FY9.323.56Positive
12/2023 FY8.280.49Positive
Next Report Date21st Jul 2022
Estimated EPS Next Report2.15
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume923.35K
Shares Outstanding117.37K
Shares Float103.36M
Trades Count16.51K
Dollar Volume129.09M
Avg. Volume995.68K
Avg. Weekly Volume1.02M
Avg. Monthly Volume934.58K
Avg. Quarterly Volume1.03M

Quest Diagnostics Incorporated (NYSE: DGX) stock closed at 140.31 per share at the end of the most recent trading day (a 2.1% change compared to the prior day closing price) with a volume of 923.35K shares and market capitalization of 16.47B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 49000 people. Quest Diagnostics Incorporated CEO is Stephen H. Rusckowski.

The one-year performance of Quest Diagnostics Incorporated stock is 6.37%, while year-to-date (YTD) performance is -18.9%. DGX stock has a five-year performance of 27.9%. Its 52-week range is between 125.33 and 174.16, which gives DGX stock a 52-week price range ratio of 30.68%

Quest Diagnostics Incorporated currently has a PE ratio of 8.70, a price-to-book (PB) ratio of 2.40, a price-to-sale (PS) ratio of 1.44, a price to cashflow ratio of 16.60, a PEG ratio of 2.32, a ROA of 13.69%, a ROC of 17.74% and a ROE of 28.56%. The company’s profit margin is 18.38%, its EBITDA margin is 28.00%, and its revenue ttm is $10.68 Billion , which makes it $90.99 revenue per share.

Of the last four earnings reports from Quest Diagnostics Incorporated, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $2.15 for the next earnings report. Quest Diagnostics Incorporated’s next earnings report date is 21st Jul 2022.

The consensus rating of Wall Street analysts for Quest Diagnostics Incorporated is Hold (2.6), with a target price of $149, which is +6.19% compared to the current price. The earnings rating for Quest Diagnostics Incorporated stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Quest Diagnostics Incorporated has a dividend yield of 2.02% with a dividend per share of $2.64 and a payout ratio of 14.00%.

Quest Diagnostics Incorporated has a Buy technical analysis rating based on Technical Indicators (ADX : 7.75, ATR14 : 3.44, CCI20 : 69.99, Chaikin Money Flow : 0.12, MACD : -0.73, Money Flow Index : 53.24, ROC : 1.84, RSI : 60.06, STOCH (14,3) : 98.88, STOCH RSI : 1.00, UO : 66.32, Williams %R : -1.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Quest Diagnostics Incorporated in the last 12-months were: Catherine T. Doherty (Option Excercise at a value of $3 598 539), Catherine T. Doherty (Sold 47 347 shares of value $7 188 586 ), Gail R. Wilensky (Option Excercise at a value of $351 780), Gail R. Wilensky (Sold 6 111 shares of value $851 403 ), Michael E. Prevoznik (Option Excercise at a value of $3 365 672), Michael E. Prevoznik (Sold 59 162 shares of value $8 221 737 ), Stephen H. Rusckowski (Option Excercise at a value of $72 219 187), Stephen H. Rusckowski (Sold 760 455 shares of value $106 589 752 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (20.00 %)
2 (20.00 %)
3 (30.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
8 (80.00 %)
8 (80.00 %)
7 (70.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.60
Hold
2.60
Moderate Buy
2.40

Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of nearly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

CEO: Stephen H. Rusckowski

Telephone: +1 973 520-2700

Address: 500 Plaza Drive, Secaucus 07094, NJ, US

Number of employees: 49 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

TipRanks News for DGX

News

Stocktwits